InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the complete record of transactions filed by Bell Michael Brian, 首席财务官. Director active across 1 company, notably Guardant Health, Inc.. In total, 38 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €221k. History available since 15 January 2022. The latest transaction was disclosed on 5 June 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Bell Michael Brian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报38 总计
2,084 股Common StockSEC:0001702824-26-000014:0
3,324 股Common StockSEC:0001702824-26-000014:1
1,870 股Common StockSEC:0001702824-26-000014:2
3,914 股Common StockSEC:0001702824-26-000014:3
2,039 股Common StockSEC:0001702824-26-000012:0
1,096 股Common StockSEC:0001702824-26-000012:1
2,000 股@ US$128.62030.011% mcap85.7% 占其流量Common StockSEC:0001702824-26-000010:0
2,084 股0Common StockSEC:0001702824-26-000008:0
3,324 股0Common StockSEC:0001702824-26-000008:1
7,369 股0Common StockSEC:0001702824-26-000008:2
6,869 股@ US$91.1567.6% 占其流量Common StockSEC:0001702824-26-000008:3
1,233 股0Common StockSEC:0001702824-26-000006:0
10,520 股0Common StockSEC:0001702824-26-000002:0
1,233 股0Common StockSEC:0001702824-25-000010:0
29,382 股@ US$32.8650.9% 占其流量Common StockSEC:0001702824-25-000008:0
2,084 股0Common StockSEC:0001702824-25-000006:0
1,233 股0Common StockSEC:0001702824-25-000004:0
2,084 股0Common StockSEC:0001576280-25-000215:0
1,233 股0Common StockSEC:0001576280-25-000183:0
2,084 股0Common StockSEC:0001576280-25-000110:0
1,233 股0Common StockSEC:0001576280-25-000088:0
7,108 股0Common StockSEC:0001576280-25-000050:0
6,617 股0Common StockSEC:0001576280-25-000034:0
3,309 股0Common StockSEC:0001576280-25-000022:0
2,084 股0Common StockSEC:0001576280-25-000008:0
38 条申报中的 25 条
About Bell Michael Brian
Bell Michael Brian is Chief Financial Officer at Guardant Health, Inc. He has 38 filings in total, and within the sampled recent filings, sales total EUR 221484, over the period from 2022-01-18 to 2026-07-02.
